461 related articles for article (PubMed ID: 35844506)
1. Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy.
Catanzaro E; Feron O; Skirtach AG; Krysko DV
Front Immunol; 2022; 13():925290. PubMed ID: 35844506
[TBL] [Abstract][Full Text] [Related]
2. An emerging role for nanomaterials in increasing immunogenicity of cancer cell death.
Mishchenko T; Mitroshina E; Balalaeva I; Krysko O; Vedunova M; Krysko DV
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):99-108. PubMed ID: 30528646
[TBL] [Abstract][Full Text] [Related]
3. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicines for an Enhanced Immunogenic Cell Death-Based
Zhao C; Wang C; Shan W; Wang Z; Chen X; Deng H
Acc Chem Res; 2024 Mar; 57(6):905-918. PubMed ID: 38417027
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy.
Wang J; Ma J; Xie F; Miao F; Lv L; Huang Y; Zhang X; Yu J; Tai Z; Zhu Q; Bao L
Front Immunol; 2024; 15():1389173. PubMed ID: 38745666
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic cell death in cancer immunotherapy.
Choi M; Shin J; Lee CE; Chung JY; Kim M; Yan X; Yang WH; Cha JH
BMB Rep; 2023 May; 56(5):275-286. PubMed ID: 37081756
[TBL] [Abstract][Full Text] [Related]
7. Cancer Immunotherapy Elicited by Immunogenic Cell Death Based on Smart Nanomaterials.
Yang M; Zhang C; Wang R; Wu X; Li H; Yoon J
Small Methods; 2023 May; 7(5):e2201381. PubMed ID: 36609838
[TBL] [Abstract][Full Text] [Related]
8. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
[TBL] [Abstract][Full Text] [Related]
9. Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems.
Peng J; Li S; Ti H
Int J Nanomedicine; 2024; 19():5895-5930. PubMed ID: 38895146
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
[TBL] [Abstract][Full Text] [Related]
11. The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses.
Aaes TL; Vandenabeele P
Cell Death Differ; 2021 Mar; 28(3):843-860. PubMed ID: 33214663
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
[TBL] [Abstract][Full Text] [Related]
13. Interrelation between Programmed Cell Death and Immunogenic Cell Death: Take Antitumor Nanodrug as an Example.
Meng Q; Ding B; Ma P; Lin J
Small Methods; 2023 May; 7(5):e2201406. PubMed ID: 36707416
[TBL] [Abstract][Full Text] [Related]
14. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
Garg AD; Agostinis P
Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
[TBL] [Abstract][Full Text] [Related]
15. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches.
Elzoghby AO; Samir O; Emam HE; Soliman A; Abdelgalil RM; Elmorshedy YM; Elkhodairy KA; Nasr ML
Acta Pharm Sin B; 2024 Jun; 14(6):2475-2504. PubMed ID: 38828160
[TBL] [Abstract][Full Text] [Related]
16. Trial watch: chemotherapy-induced immunogenic cell death in oncology.
Sprooten J; Laureano RS; Vanmeerbeek I; Govaerts J; Naulaerts S; Borras DM; Kinget L; Fucíková J; Špíšek R; Jelínková LP; Kepp O; Kroemer G; Krysko DV; Coosemans A; Vaes RDW; De Ruysscher D; De Vleeschouwer S; Wauters E; Smits E; Tejpar S; Beuselinck B; Hatse S; Wildiers H; Clement PM; Vandenabeele P; Zitvogel L; Garg AD
Oncoimmunology; 2023; 12(1):2219591. PubMed ID: 37284695
[TBL] [Abstract][Full Text] [Related]
17. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death.
Jin F; Liu D; Xu X; Ji J; Du Y
Int J Nanomedicine; 2021; 16():4693-4712. PubMed ID: 34267518
[TBL] [Abstract][Full Text] [Related]
18. Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology.
Vanmeerbeek I; Sprooten J; De Ruysscher D; Tejpar S; Vandenberghe P; Fucikova J; Spisek R; Zitvogel L; Kroemer G; Galluzzi L; Garg AD
Oncoimmunology; 2020; 9(1):1703449. PubMed ID: 32002302
[TBL] [Abstract][Full Text] [Related]
19. Evoking Highly Immunogenic Ferroptosis Aided by Intramolecular Motion-Induced Photo-Hyperthermia for Cancer Therapy.
Chen C; Wang Z; Jia S; Zhang Y; Ji S; Zhao Z; Kwok RTK; Lam JWY; Ding D; Shi Y; Tang BZ
Adv Sci (Weinh); 2022 Apr; 9(10):e2104885. PubMed ID: 35132824
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic ferroptosis and where to find it?
Demuynck R; Efimova I; Naessens F; Krysko DV
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
